Quest PharmaTech Brief: Says Quest Has a 42.5% Ownership Interest in OncoQuest; Adds Dividend Income Will Be Used by Quest for General Corporate Purposes

05:07 PM EST, 01/30/2024 (MT Newswires) -- Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes

MT NewswiresJan 30 16:07

Quest PharmaTech Brief: Received a Cash Dividend Payment From OncoQuest Inc. of Approximately C$685,000

05:07 PM EST, 01/30/2024 (MT Newswires) -- Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000

MT NewswiresJan 30 16:07

Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis

Quest PharmaTech Inc. (QPT.V), a pharmaceutical company, trading near 52 week lows, overnight Tuesday said it has been advised that the Phase III clinical trial of oregovomab for the treatment of ovar

MT NewswiresJan 24 06:07

Quest PharmaTech Provides Corporate Update

Stockhouse Sep 13, 2023 15:15

Quest PharmaTech Announces Results From AGM

Stockhouse Jul 14, 2023 15:30

Quest PharmaTech Provides Product Development Update

Stockhouse Jul 10, 2023 15:30